GlassScriptPhysician profile
Lillian Cohn
NPI 1538160825
$9,945.43
in general payments reported to CMS, 2019-2025
48 companies · $2,895 in 2025
The $2,895 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,884 · 2020: $505 · 2021: $75.97 · 2022: $102 · 2023: $1,529 · 2024: $2,953 · 2025: $2,895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,362 · Education: $15.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,361.65 |
| Education | $15.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,348.05 | 2019-2025 | |
| Novo Nordisk INC | $1,335.11 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $1,043.68 | 2023-2025 | Ubrelvy, Linzess, Viberzi |
| Lilly USA, LLC | $1,040.44 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Astrazeneca Pharmaceuticals LP | $466.22 | 2019-2025 | Airsupra, Farxiga |
| Amgen INC. | $465.13 | 2019-2025 | Evenity, Otezla, Repatha |
| Astellas Pharma US INC | $460.13 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $320.13 | 2019-2025 | Synjardy, Jardiance, Tradjenta |
| Eisai INC. | $251.56 | 2023-2025 | |
| Gilead Sciences, INC. | $227.44 | 2019-2025 | Yeztugo |
| Bayer Healthcare Pharmaceuticals INC. | $214.12 | 2024-2025 | |
| Amarin Pharma, INC. | $205.68 | 2019-2020 | |
| Insulet Corporation | $179.58 | 2025 | Omnipod |
| E.R. Squibb & Sons, L.L.C. | $176.19 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $175.72 | 2019-2025 |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $163.90 | 2024-2025 | Gemtesa |
| Inspire Medical Systems, INC. | $144.88 | 2023-2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $141.62 | 2019-2020 | |
| Glaxosmithkline, LLC. | $118.92 | 2019-2025 | Shingrix, Arexvy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $115.77 | 2019-2025 | Xifaxan |
| Exact Sciences Corporation | $101.63 | 2023-2025 | Cologuard Collection Kit |
| Viiv Healthcare Company | $87.89 | 2024 | Apretude |
| Biohaven Pharmaceutical Holding Company LTD. | $84.92 | 2022 | |
| Sanofi-Aventis U.S. LLC | $79.41 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $75.36 | 2019-2025 | Capvaxive |
| Boston Scientific Corporation | $70.96 | 2023-2024 | Bodyguardian |
| Esperion Therapeutics, INC. | $70.80 | 2024 | Nexletol |
| Paratek Pharmaceuticals, INC. | $70.09 | 2024 | Nuzyra |
| Radius Health, INC. | $68.87 | 2019-2024 | Tymlos |
| Hologic Sales and Service, LLC | $66.02 | 2023-2025 | Aptima |
| Allergan, INC. | $63.46 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $56.88 | 2024 | Abilify Mycite, Rexulti |
| Seqirus USA INC | $45.64 | 2019-2024 | Fluad, Flucelvax |
| Sanofi Pasteur INC. | $42.31 | 2019 | |
| Janssen Pharmaceuticals, INC | $37.98 | 2019 | |
| Neurocrine Biosciences, INC. | $37.72 | 2023-2024 | Ingrezza |
| Shire North American Group INC | $35.42 | 2019 | |
| Inari Medical, INC. | $31.97 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Regeneron Healthcare Solutions, INC. | $30.18 | 2019 | |
| Qol Medical, LLC | $29.08 | 2025 | Sucraid |
| Agios Pharmaceuticals, INC. | $28.86 | 2024 | Pyrukynd |
| Dexcom, INC. | $26.80 | 2023 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $24.72 | 2024 | Gvoke Hypopen |
| Bausch Health US, LLC | $23.17 | 2025 | Wellbutrin |
| Idorsia Pharmaceuticals US INC | $17.74 | 2023 | Quviviq |
| Medtronic, INC. | $17.48 | 2022 | |
| Circassia INC. | $14.46 | 2019 | |
| Acarix USA INC. | $11.34 | 2024 | Cadscor System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lillian Cohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.